
Peptides
Last Updated
Apr 19, 2026
Table of contents
If you've followed peptide therapy in the last three years, you've watched the access landscape swing from open compounding to FDA restriction and now back toward reopening. As of April 2026, prescription peptides are legally accessible through licensed telehealth clinics working with 503A and 503B compounding pharmacies — and the formulary is about to get meaningfully broader. Here's where things actually stand.
The 2023–2024 FDA Restriction
In September 2023, the FDA began moving popular peptides to Category 2 of its interim 503A bulk drug substances list. A Category 2 designation effectively blocks licensed compounding pharmacies from preparing the substance under Section 503A of the Federal Food, Drug, and Cosmetic Act. By late 2024, nineteen peptides had been placed on the restricted list — including BPC-157, TB-500 (Thymosin Beta-4), CJC-1295, Ipamorelin, Thymosin Alpha-1, AOD-9604, and several growth hormone secretagogues. Patients who had been accessing these through licensed telehealth clinics lost that pathway practically overnight.
The enforcement didn't stop at compounding pharmacies. In December 2024, the FDA issued warning letters to research peptide vendors Prime Peptides, Xcel Peptides, SwissChems, and Summit Research for marketing semaglutide, tirzepatide, and retatrutide as unapproved drugs. Research chemical vendor Amino Asylum was raided by the FDA in June 2025. Peptide Sciences, one of the largest gray-market research peptide suppliers in the country, voluntarily shut down in March 2026. Eli Lilly's International Trade Commission complaint against tirzepatide importers produced a General Exclusion Order in January 2025 blocking all infringing tirzepatide imports.
The RFK Jr. Reversal — February 27, 2026
On February 27, 2026, HHS Secretary Robert F. Kennedy Jr. appeared on The Joe Rogan Experience (episode #2461) and announced that approximately fourteen of the nineteen Category 2 peptides would be moved back to Category 1 — restoring legal compounding access. Kennedy's stated position was that the FDA had been overly restrictive and that patients should be able to access peptides through ethical, licensed suppliers rather than being pushed toward gray-market research chemical vendors.
As of April 2026, the formal Federal Register notice has not yet published, and the Pharmacy Compounding Advisory Committee (PCAC) has not completed its review of the affected substances. Five peptides — CJC-1295, Ipamorelin, Thymosin Alpha-1, AOD-9604, and Selank — are under active PCAC review. The policy direction is clear, but the timeline isn't. Full legal compounding access to the reinstated peptides is expected to roll out through Q2 and Q3 2026, as the formal rulemaking process catches up with the announced policy shift.
What This Means for Patients Right Now
Two things matter for anyone considering peptide therapy today.
First, the clinics that stayed operational through the 2023–2025 enforcement cycle did so by working within the compounding pharmacy framework — licensed physicians, disclosed 503A or 503B pharmacies, real bloodwork, real oversight. Those survivors are the clinics ranked below. Research chemical vendors that ship unmarked vials to residential addresses increasingly sit outside the legal framework, regardless of how their labeling reads; the FDA's March 2025 Final Guidance presumes peptides shipped to homes are intended for human use no matter what the label says.
Second, peptides that were hard to access in 2024 and 2025 are coming back. If BPC-157, CJC-1295/Ipamorelin, TB-500, or Thymosin Alpha-1 are on your list, the access picture in Q3 2026 will be substantially better than it was in Q1. Clinics already positioned within the compounding framework are set to expand their formularies as soon as the formal Category 1 reinstatement publishes.
This review ranks the best telehealth clinics for prescription peptide therapy in 2026, focused on the therapeutic peptides most readers are actually searching for: BPC-157, sermorelin, CJC-1295/ipamorelin, TB-500, thymosin alpha-1, PT-141, GHK-Cu, and NAD+. GLP-1 weight-loss medications are a separate category with a different set of best providers and are not covered here. Nothing in this article is medical advice — peptide therapy should be started and monitored by a licensed clinician working with a US-based compounding pharmacy.
How We Scored These Clinics
Every clinic was scored on five criteria, each worth 2 points for a maximum score of 10:
Formulary breadth — how many peptides the clinic actually prescribes
Clinical depth — who's writing the prescription, what bloodwork is required, how monitoring works
Price and transparency — published pricing, clarity on inclusions, lab-cost handling
Accessibility — state coverage, telehealth infrastructure, ease of getting started
Reputation — time in market, patient reviews, regulatory standing, pharmacy partner records
The Rankings at a Glance
#1 Maximus — 9.3 / 10 — Top Pick Overall. All 50 states, $199/mo with labs included, first month free.
#2 TRT Nation — 8.8 / 10 — Best Value. $99/mo flat-rate TRT with BPC-157 add-on, no contracts.
#3 Defy Medical — 9.0 / 10 — Broadest Formulary. 15+ peptides, fellowship-trained MDs, $200–$650/mo.
#4 Marek Health — 8.8 / 10 — Data-Driven Optimization. 60+ biomarker panels, $166+/mo base plus labs.
#5 Victory Select — 7.2 / 10 — Broad Regional Formulary. 15+ peptides, Texas-based, verify state coverage.
#6 Blue Sky MD — 6.8 / 10 — Regional Care. North Carolina hybrid in-person + telehealth model.
Featured Clinic Reviews
Each clinic below is reviewed against the same five criteria. Rankings reflect overall score, but the best clinic for you depends on what you're trying to solve — recovery peptides, growth hormone support, or longevity protocols each point toward different providers.
#1 Maximus — Best Overall for Most Patients (9.3 / 10)
Maximus is the most accessible legitimate peptide clinic in the US — licensed in all 50 states, $199/month flat with labs included, and physician-led care through LegitScript-certified US compounding pharmacies. The peptide focus is sermorelin-forward (their flagship growth hormone protocol), with TRT and fertility-preserving options available through the same platform. The "first month free" promotion makes it the easiest low-commitment entry into serious peptide therapy.
What stands out:
All 50 states — solves the geographic restriction problem
$199/month flat rate with labs included
First month free promotion for new patients
At-home lab testing — no lab visits required
Physician-designed sermorelin protocol with before/after IGF-1 labs
Community coaching built into the program
What's special: The combination of all-inclusive pricing, 50-state coverage, and a trial-friendly entry point makes Maximus the best starting clinic for patients new to peptide therapy who want TRT and growth hormone peptides from the same provider. The at-home lab kits eliminate one of the biggest friction points in telehealth care.
Worth knowing: Narrower formulary than Defy or Marek — sermorelin is the primary peptide, without BPC-157, TB-500, or CJC-1295 as standalone protocols. Best fit for patients whose goals center on growth hormone optimization rather than recovery or longevity peptide stacking.
Promo: First month free — verify availability on site.
#2 TRT Nation — Best Value (8.8 / 10)
TRT Nation is built around $99/month flat-rate testosterone replacement with no contracts, unlimited consultations, and a formulary that extends beyond just testosterone. Established patients can add BPC-157, tadalafil, enclomiphene, HCG, and nandrolone to their protocol without switching clinics. Best value in the TRT category.
What stands out:
$99/month flat-rate TRT — lowest serious price in category
No contracts, no commitment, cancel anytime
Unlimited consultations at no additional cost
BPC-157 available as add-on for established patients
No prepay required before first consultation
Home delivery of medications and supplies
What's special: The no-contract, unlimited-consult structure is genuinely rare. Most TRT clinics charge per visit or per call; TRT Nation treats ongoing access as core to the product. For TRT patients who want to layer in a recovery peptide, this is the most affordable way to do it through a single clinical relationship.
Worth knowing: Not a peptide-forward clinic. BPC-157 is a secondary offering; no growth hormone secretagogues, no recovery peptides beyond BPC-157, no longevity compounds. If peptide therapy is your primary goal rather than TRT with peptide add-ons, look at Defy, Marek, or Maximus instead.
Pricing: $99/mo flat, no contracts, unlimited consults included.
#3 Defy Medical — Broadest Peptide Formulary (9.0 / 10)
Defy Medical is a Tampa-based concierge practice with nationwide telehealth reach and the deepest peptide formulary in the industry. Fellowship-trained medical directors lead a team of physicians who specialize in interventional endocrinology and hormone restoration. If you want BPC-157, TB-500, PT-141, GHK-Cu, thymosin alpha-1, or epithalon — any of the less common peptides — Defy is almost always the first call.
What stands out:
15+ peptides across recovery, growth hormone, longevity, and sexual health
Fellowship-trained medical directors and physician-level prescribers
Up to one-hour consultations with your prescriber
Full hormone and metabolic lab panels with nationwide lab access
In-person Tampa option plus nationwide telehealth
Evening and Saturday provider availability
What's special: Defy is one of the few clinics where you can discuss and receive a full spectrum of peptide and hormone protocols in a single relationship, without referral chains or formulary restrictions. Cash-pay only, but the tradeoff is access to treatments most insurance-based practices refuse to touch. Basic TRT runs $200–$350/month; comprehensive peptide protocols can reach $400–$650/month.
Worth knowing: No insurance acceptance. Patient portal is functional but showing its age compared to newer platforms. $149 initial consultation fee is non-refundable. Best fit for experienced patients who know what they want rather than first-timers wanting hand-holding.
#4 Marek Health — Best for Optimization (8.8 / 10)
Marek Health built its reputation on data. Standard panels test 60+ biomarkers, which is a full level deeper than almost any competitor. The clinic's philosophy leans heavily on preventative health rather than just hormone replacement, and the patient base tends to come in with meaningful baseline knowledge, which pushes the clinical bar higher.
What stands out:
60+ biomarker panels — deepest data in the telehealth category
MD and DO prescribers with research-driven protocol design
Monthly consultations built into the program
Strong peptide formulary alongside comprehensive TRT
Functional medicine philosophy catches issues hormone-only clinics miss
HSA/FSA eligible
What's special: Marek's patient base is unusually educated — many come in already familiar with hormone optimization from independent research. That shifts the clinical conversation from basic education to genuine optimization. For patients who want to understand every aspect of their metabolic and hormonal health, the depth of testing is unmatched in telehealth.
Worth knowing: Most expensive option when fully loaded. Base is $166+/month but labs add $450–$1,700/year depending on panel depth — the all-in annual cost can exceed even Defy's premium pricing. Can feel overbuilt for patients with simple needs.
#5 Victory Select — Broadest Regional Formulary (7.2 / 10)
Victory Select operates as an online pharmacy and telehealth clinic based in Texas with one of the broader formularies in the regional-clinic category. The menu covers CJC-1295/ipamorelin, BPC-157, tesamorelin, AOD-9604, GHK-Cu, sermorelin, selank, KPV, MOTS-c, thymosin beta-4, thymosin alpha-1, epithalon, and PT-141.
What stands out:
15+ peptides — rivals Defy Medical for breadth
Coverage of less common peptides (selank, KPV, MOTS-c)
Online pharmacy model simplifies dispensing
Telehealth consultations with licensed prescribers
Competitive pricing relative to premium national clinics
Specialty peptides that most national telehealth clinics don't carry
What's special: For patients in states where Victory Select is licensed, the formulary breadth rivals Defy Medical at typically lower pricing. This is the best option for patients who want access to specialty peptides like KPV or MOTS-c without paying Defy's concierge premium.
Worth knowing: Regional limits — verify state coverage before signing up. Pricing is less transparent upfront than top-ranked clinics; most protocols require a consultation to get a quote. Less published clinical depth than national specialty clinics.
#6 Blue Sky MD — Regional Care with In-Person Option (6.8 / 10)
Blue Sky MD is a North Carolina-based bioidentical hormone and peptide clinic with a practical telehealth arm for existing patients. Best option if you're in-state and value the ability to combine in-person visits with telehealth follow-ups — the hybrid model that most national telehealth clinics can't offer.
What stands out:
8+ peptides with HRT-integrated protocols
In-person + telehealth hybrid care model
Established North Carolina presence
Bioidentical hormone replacement specialty
Continuity of care for regional patients
Long-standing local reputation
What's special: The hybrid care model is genuinely rare. Most peptide therapy happens entirely over video; Blue Sky MD lets you walk into a physical clinic when you want a harder-to-diagnose issue looked at. For North Carolina residents, this combination is difficult to find anywhere else in the peptide space.
Worth knowing: Regional only. Not a good option if you're outside North Carolina or nearby states. Formulary is narrower than top-ranked national clinics. Pricing varies by protocol and isn't published upfront.
What Peptides Are Actually Prescribable in 2026
Three legal categories matter, and they get confused constantly.
FDA-approved peptide drugs are standard prescription medications. Tesamorelin, PT-141 (bremelanotide), and several others have full FDA approval for specific indications and fill at any pharmacy.
Compounded peptides are prepared by 503A pharmacies (patient-specific prescription) or 503B outsourcing facilities (bulk compounding under FDA oversight) using bulk drug substances that are either FDA-approved, have a USP monograph, or appear on the 503A bulks list in Category 1. Sermorelin and NAD+ are long-standing examples. As of early 2026, BPC-157, TB-500, CJC-1295, ipamorelin, and thymosin alpha-1 are returning to Category 1 after the RFK Jr. reclassification announcement.
Controlled substance peptides sit in a separate framework. Synthetic human growth hormone (somatropin) is Schedule III with strict federal prescribing requirements. This is distinct from growth hormone-releasing peptides like sermorelin, ipamorelin, and CJC-1295, which stimulate the pituitary to produce its own GH. Legitimate peptide therapy overwhelmingly uses secretagogues, not synthetic HGH.
The specific peptides available through the top-ranked clinics in 2026:
Recovery and tissue repair: BPC-157, TB-500 (Thymosin Beta-4), GHK-Cu
Growth hormone secretagogues: Sermorelin, Ipamorelin, CJC-1295, Tesamorelin
Longevity and immune: Thymosin Alpha-1, NAD+, Epithalon, Selank
Sexual health: PT-141, compounded oxytocin
Specialty: MOTS-c, KPV, AOD-9604, 5-Amino-1MQ
How to Evaluate Any Peptide Clinic
Five things separate a legitimate telehealth peptide clinic from a marginal one.
A named, licensed prescriber. You should see who's writing your prescription and which state they're licensed in. MDs and DOs have deeper training than NPs and PAs, though all three can prescribe legitimately. A clinic that won't name its prescribers is hiding something.
A disclosed compounding pharmacy. The clinic should tell you which 503A or 503B pharmacy fills your prescription. State boards publish disciplinary records; a quick check flags pharmacies with recent citations.
Baseline and follow-up bloodwork. Any clinic prescribing peptides without labs is cutting corners that matter. Minimum baseline for TRT includes total testosterone, free testosterone, estradiol, CBC, CMP, lipid panel, SHBG, PSA (for men 40+), and TSH. Add IGF-1 for growth hormone peptides and hs-CRP for long-term protocols. Reasonable cadence is 6–8 weeks post-initiation, then every 3–6 months.
Dose titration and clinician access. Peptide protocols change as your body responds. A single prescription followed by radio silence is a red flag. You should be able to message your clinician when side effects or questions come up.
Cold-chain shipping for injectables. Many peptides are heat-sensitive. Shipments should arrive insulated with cold packs. Unlabeled vials, missing pharmacy information, or melted ice packs are all reasons to push back.
Clear red flags: selling peptides without a prescription step, crypto-only payment, unmarked vials, "starting at" pricing that hides real cost at clinical doses, no privacy policy, or pressure to buy bundles before the first clinician call.
Getting Started
Figure out what you're solving for first. Recovery and tissue repair (BPC-157, TB-500), growth hormone support (sermorelin, ipamorelin, CJC-1295), longevity (NAD+, epithalon, thymosin alpha-1), or sexual health (PT-141) — each points toward a different clinic ranking.
Bring recent bloodwork if you have it. Any legitimate clinic will order baseline labs, but results within the last six months from your regular doctor can save a cycle and reduce upfront costs.
Start with one clinic. The temptation to run TRT from one provider and wellness peptides from another creates fragmented care and dangerous prescribing conflicts. Pick the clinic that covers your primary goal and has breadth for adjacencies.
Budget for ongoing monitoring. Most clinics don't include labs in the headline monthly fee. Expect $200–$1,500 per year depending on panel depth and frequency.
Keep your own records. Save every prescription, lab result, and clinician note. Clinics sometimes close, patients move states, and continuity depends on having your history in one place.
Lifelong Optimization
Not your average
Checkup
Every life stage brings new biological demands. Tracking the right metrics at the right time helps you adapt, optimize performance, and extend both lifespan and healthspan.
Traditional
Manual Data Processing
Guesswork Trend Detection
Slow Campaign Setup
Multiple Tools, Multiple Logins
Reactive Decision-Making
Manual Reporting
Delayed Results
High Error Risk
Automated Data Sync
Real-Time Trend Insights
Instant AI Optimization
All-in-One Platform
Proactive AI-Driven Strategies
Auto-Generated Reports
Instant Performance Updates
AI Precision
Frequently Asked Qustions
Clarity before you commit
Answers on setup, scale, and support to remove blockers.


